Century Therapeutics (IPSC) | Portfolio | Versant Ventures

← View Portfolio

Century Therapeutics is harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer.

Company Name

Century Therapeutics (IPSC)

Company Website

https://www.centurytherapeutics.com/

Location

Philadelphia, PA

Investment Stage

IPO June 2021

Connected News

Century Therapeutics Completes $160 Million Series C Financing to Accelerate Development of iPSC-derived Cell Therapy Pipeline
Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform